Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

TSHATSHA
Showing 8 of 12 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in TAYSHA GENE THERAPIES INC

BAKER BROS. ADVISORS LP holds 4M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $27.3M as of 2026-Q2. TSHA represents 0.1% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$27.3M

Current Shares

4M

Total Value Change

+$19.2M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
4M
0.0%
$27.3M0.1%$6.81
0
2026-Q1
Unchanged
4M
0.0%
$17.9M0.1%$4.53
0
2025-Q4
Unchanged
4M
0.0%
$22M0.1%$5.66
0
2025-Q3
Unchanged
4M
0.0%
$13.1M0.1%$3.16
0
2025-Q2
Unchanged
4M
0.0%
$9.3M0.1%$2.38
0
2025-Q1
Unchanged
4M
0.0%
$5.6M0.1%$1.93
0
2024-Q4
Unchanged
4M
0.0%
$6.9M0.1%$1.73
0
2024-Q3
Unchanged
4M
0.0%
$8M0.1%$2.07
0

Other major holders of TSHA: Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used